Previous Close | 40.00 |
Open | 40.70 |
Bid | 38.00 x N/A |
Ask | 42.00 x N/A |
Day's Range | 40.70 - 40.70 |
52 Week Range | 36.00 - 134.70 |
Volume | |
Avg. Volume | 11,947 |
Market Cap | 27.619M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.70 |
10 January 2023 Aptamer Group plc(“Aptamer”, the “Company” or the “Group”) Appointment of Interim Chief Commercial Officer Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, today announces the appointment of Derek Smith as Interim Chief Commercial Officer, effective as of 1st January 2023. Derek joined the Company in 2018 as Director of Global Sales and has since become a vital part of the Aptamer team, overseeing the devel
UK firm links with up global drug firms to make synthetic antibodies capable of binding to targets such as tumour cells